Review



tf  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    R&D Systems tf
    Tf, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+tf/pm41850278-177-211-214?v=R%26D+Systems
    Average 94 stars, based on 2 article reviews
    tf - by Bioz Stars, 2026-07
    94/100 stars

    Images



    Similar Products

    tfs target  (TargetMol)
    94
    TargetMol tfs target
    Tfs Target, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+tf/pm41789592-234-87-370?v=TargetMol
    Average 94 stars, based on 1 article reviews
    tfs target - by Bioz Stars, 2026-07
    94/100 stars
    		  Buy from Supplier
    tf  (R&D Systems)
    94
    R&D Systems tf
    Tf, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+tf/pm41850278-177-211-214?v=R%26D+Systems
    Average 94 stars, based on 1 article reviews
    tf - by Bioz Stars, 2026-07
    94/100 stars
    		  Buy from Supplier
    recombinant purified human tf innovin  (Fisher Scientific)
    86
    Fisher Scientific recombinant purified human tf innovin
    Recombinant Purified Human Tf Innovin, supplied by Fisher Scientific, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+tf/10__1016_slash_j__rpth__2026__103353-51-7-12?v=Fisher+Scientific
    Average 86 stars, based on 1 article reviews
    recombinant purified human tf innovin - by Bioz Stars, 2026-07
    86/100 stars
    		  Buy from Supplier
    human recombinant lipidated tf  (BioMedica Diagnostics)
    90
    BioMedica Diagnostics human recombinant lipidated tf
    Human Recombinant Lipidated Tf, supplied by BioMedica Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+tf/pmc07805334-38-16-19?v=BioMedica+Diagnostics
    Average 90 stars, based on 1 article reviews
    human recombinant lipidated tf - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    human tf-fviia, recombinant  (American Diagnostica)
    90
    American Diagnostica human tf-fviia, recombinant
    Human Tf Fviia, Recombinant, supplied by American Diagnostica, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+tf/pm40378577-546-2-8?v=American+Diagnostica
    Average 90 stars, based on 1 article reviews
    human tf-fviia, recombinant - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    biotinylated recombinant his-tagged human tf antibody  (Meso Scale Diagnostics LLC)
    90
    Meso Scale Diagnostics LLC biotinylated recombinant his-tagged human tf antibody
    Biotinylated Recombinant His Tagged Human Tf Antibody, supplied by Meso Scale Diagnostics LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+tf/pmc11791478-124-13-17?v=Meso+Scale+Diagnostics+LLC
    Average 90 stars, based on 1 article reviews
    biotinylated recombinant his-tagged human tf antibody - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    recombinant human relipidated tf  (BioMedica Diagnostics)
    90
    BioMedica Diagnostics recombinant human relipidated tf
    Recombinant Human Relipidated Tf, supplied by BioMedica Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+tf/pm39858477-59-12-14?v=BioMedica+Diagnostics
    Average 90 stars, based on 1 article reviews
    recombinant human relipidated tf - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    tisotumab, an anti-human tf recombinant monoclonal antibody (mab)  (Creative Biolabs)
    90
    Creative Biolabs tisotumab, an anti-human tf recombinant monoclonal antibody (mab)
    Delivery of <t>tisotumab</t> or tiso-IR700 and efficacy of in vivo TF-targeted NIR-PIT in the HPAF-II subcutaneous xenograft model. A , Tumors were harvested 24 h after injecting tiso-DIG or isotype-DIG into mice and the distribution in HPAF-II tumors was examined by multiplex immunohistochemistry ( n = 4; images, × 200; scale bar, 100 μm). DIG and pCK are shown in green and purple, respectively. tiso-DIG, digoxigenin (DIG)-conjugated tisotumab. B , In vivo fluorescence imaging of tiso-IR700. Representative fluorescence images at 700 nm in an HPAF-II tumor bearing mouse. All images were acquired at the indicated time points after injecting tiso-IR700 into mice. AU, arbitrary units. C , Quantitative analysis of target-to-background ratio after injecting tiso-IR700 ( n = 5). D , Treatment schedule. E , Representative 700-nm fluorescence images before and after NIR-PIT. F , Tumor volume curves ( n = 10–11; mean ± SEM; repeated measures two-way repeated measures ANOVA followed by Tukey's test); *, p < 0.05; **, p < 0.01; *** p < 0.001; ****, p < 0.0001 versus the Control group. G , Survival curves ( n = 10–11, log-rank test with Bonferroni correction); ***, p < 0.001
    Tisotumab, An Anti Human Tf Recombinant Monoclonal Antibody (Mab), supplied by Creative Biolabs, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+tf/pmc11699179-43-0-11?v=Creative+Biolabs
    Average 90 stars, based on 1 article reviews
    tisotumab, an anti-human tf recombinant monoclonal antibody (mab) - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    anti-human tf recombinant monoclonal antibody (mab)  (Creative Biolabs)
    90
    Creative Biolabs anti-human tf recombinant monoclonal antibody (mab)
    Delivery of <t>tisotumab</t> or tiso-IR700 and efficacy of in vivo TF-targeted NIR-PIT in the HPAF-II subcutaneous xenograft model. A , Tumors were harvested 24 h after injecting tiso-DIG or isotype-DIG into mice and the distribution in HPAF-II tumors was examined by multiplex immunohistochemistry ( n = 4; images, × 200; scale bar, 100 μm). DIG and pCK are shown in green and purple, respectively. tiso-DIG, digoxigenin (DIG)-conjugated tisotumab. B , In vivo fluorescence imaging of tiso-IR700. Representative fluorescence images at 700 nm in an HPAF-II tumor bearing mouse. All images were acquired at the indicated time points after injecting tiso-IR700 into mice. AU, arbitrary units. C , Quantitative analysis of target-to-background ratio after injecting tiso-IR700 ( n = 5). D , Treatment schedule. E , Representative 700-nm fluorescence images before and after NIR-PIT. F , Tumor volume curves ( n = 10–11; mean ± SEM; repeated measures two-way repeated measures ANOVA followed by Tukey's test); *, p < 0.05; **, p < 0.01; *** p < 0.001; ****, p < 0.0001 versus the Control group. G , Survival curves ( n = 10–11, log-rank test with Bonferroni correction); ***, p < 0.001
    Anti Human Tf Recombinant Monoclonal Antibody (Mab), supplied by Creative Biolabs, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+tf/pm39751657-45-2-11?v=Creative+Biolabs
    Average 90 stars, based on 1 article reviews
    anti-human tf recombinant monoclonal antibody (mab) - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    recombinant human tissue factor (tf) innovin  (Marburg GmbH)
    90
    Marburg GmbH recombinant human tissue factor (tf) innovin
    Delivery of <t>tisotumab</t> or tiso-IR700 and efficacy of in vivo TF-targeted NIR-PIT in the HPAF-II subcutaneous xenograft model. A , Tumors were harvested 24 h after injecting tiso-DIG or isotype-DIG into mice and the distribution in HPAF-II tumors was examined by multiplex immunohistochemistry ( n = 4; images, × 200; scale bar, 100 μm). DIG and pCK are shown in green and purple, respectively. tiso-DIG, digoxigenin (DIG)-conjugated tisotumab. B , In vivo fluorescence imaging of tiso-IR700. Representative fluorescence images at 700 nm in an HPAF-II tumor bearing mouse. All images were acquired at the indicated time points after injecting tiso-IR700 into mice. AU, arbitrary units. C , Quantitative analysis of target-to-background ratio after injecting tiso-IR700 ( n = 5). D , Treatment schedule. E , Representative 700-nm fluorescence images before and after NIR-PIT. F , Tumor volume curves ( n = 10–11; mean ± SEM; repeated measures two-way repeated measures ANOVA followed by Tukey's test); *, p < 0.05; **, p < 0.01; *** p < 0.001; ****, p < 0.0001 versus the Control group. G , Survival curves ( n = 10–11, log-rank test with Bonferroni correction); ***, p < 0.001
    Recombinant Human Tissue Factor (Tf) Innovin, supplied by Marburg GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+tf/pm38863279-21-0-7?v=Marburg+GmbH
    Average 90 stars, based on 1 article reviews
    recombinant human tissue factor (tf) innovin - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Delivery of tisotumab or tiso-IR700 and efficacy of in vivo TF-targeted NIR-PIT in the HPAF-II subcutaneous xenograft model. A , Tumors were harvested 24 h after injecting tiso-DIG or isotype-DIG into mice and the distribution in HPAF-II tumors was examined by multiplex immunohistochemistry ( n = 4; images, × 200; scale bar, 100 μm). DIG and pCK are shown in green and purple, respectively. tiso-DIG, digoxigenin (DIG)-conjugated tisotumab. B , In vivo fluorescence imaging of tiso-IR700. Representative fluorescence images at 700 nm in an HPAF-II tumor bearing mouse. All images were acquired at the indicated time points after injecting tiso-IR700 into mice. AU, arbitrary units. C , Quantitative analysis of target-to-background ratio after injecting tiso-IR700 ( n = 5). D , Treatment schedule. E , Representative 700-nm fluorescence images before and after NIR-PIT. F , Tumor volume curves ( n = 10–11; mean ± SEM; repeated measures two-way repeated measures ANOVA followed by Tukey's test); *, p < 0.05; **, p < 0.01; *** p < 0.001; ****, p < 0.0001 versus the Control group. G , Survival curves ( n = 10–11, log-rank test with Bonferroni correction); ***, p < 0.001

    Journal: Cancer Immunology, Immunotherapy : CII

    Article Title: Tissue factor targeted near-infrared photoimmunotherapy: a versatile therapeutic approach for malignancies

    doi: 10.1007/s00262-024-03903-2

    Figure Lengend Snippet: Delivery of tisotumab or tiso-IR700 and efficacy of in vivo TF-targeted NIR-PIT in the HPAF-II subcutaneous xenograft model. A , Tumors were harvested 24 h after injecting tiso-DIG or isotype-DIG into mice and the distribution in HPAF-II tumors was examined by multiplex immunohistochemistry ( n = 4; images, × 200; scale bar, 100 μm). DIG and pCK are shown in green and purple, respectively. tiso-DIG, digoxigenin (DIG)-conjugated tisotumab. B , In vivo fluorescence imaging of tiso-IR700. Representative fluorescence images at 700 nm in an HPAF-II tumor bearing mouse. All images were acquired at the indicated time points after injecting tiso-IR700 into mice. AU, arbitrary units. C , Quantitative analysis of target-to-background ratio after injecting tiso-IR700 ( n = 5). D , Treatment schedule. E , Representative 700-nm fluorescence images before and after NIR-PIT. F , Tumor volume curves ( n = 10–11; mean ± SEM; repeated measures two-way repeated measures ANOVA followed by Tukey's test); *, p < 0.05; **, p < 0.01; *** p < 0.001; ****, p < 0.0001 versus the Control group. G , Survival curves ( n = 10–11, log-rank test with Bonferroni correction); ***, p < 0.001

    Article Snippet: Tisotumab, an anti-human TF recombinant monoclonal antibody (mAb), was purchased from Creative Biolabs Inc. (Shirley, NY, USA).

    Techniques: In Vivo, Multiplex Assay, Immunohistochemistry, Fluorescence, Imaging, Control